Ebola-infected surgeon dies in Omaha

Laura Pedulli | | Health Exec | Precision Medicine

 

Martin Salia, MD, a surgeon who contracted Ebola while working in Sierra Leone, died on Monday in a biocontainment center in Omaha, reports The New York Times.

“We used the maximum amount of supportive care and every advanced technique available in an effort to save his life,” said Jeffrey P. Gold, MD, chancellor of the University of Nebraska Medical Center. Salia had previously tested negative for the virus, according to the article.

Read more below:

Doctor Being Treated for Ebola in Omaha Dies

Laura Pedulli

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.